Emerging Clinical Problem of Resistance to Antiplatelet Therapy in Primary Prevention and Treatment of Cardiovascular Events in People Living with HIV: Conundrum despite Effective cART
Despite the extensive use of combined antiretroviral therapy (cART) for effective human immunodeficiency viral (HIV) suppression, people living with HIV have an increased risk of cardiovascular events compared to the general population. Antiplatelet agents are recommended for primary prevention and...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book Chapter |
| Language: | English |
| Published: |
IntechOpen
2023
|
| Subjects: | |
| Online Access: | https://www.intechopen.com/chapters/88020 |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Emerging Clinical Problem of Resistance to Antiplatelet Therapy in Primary Prevention and Treatment of Cardiovascular Events in People Living with HIV: Conundrum despite Effective cART
- Antiplatelet therapy in cardiovascular disease /
- Antiplatelet Therapy in Cardiovascular Disease – Past, Present and Future
- Dyslipidemia and Type 2 Diabetes Mellitus: Implications and Role of Antiplatelet Agents in Primary Prevention of Cardiovascular Disease
- Dual Antiplatelet Therapy
- Effect of Antiplatelet Therapy on Suboptimal Reperfusion
- Epidemiology and Therapy of People Living with HIV in Various Provinces of China